2nd Nov 2006 15:49
Synergy Healthcare PLC02 November 2006 For Immediate Release 2 November 2006 SYNERGY HEALTHCARE PLC ("Synergy" or the "Company") OFFER BY BREWIN DOLPHIN SECURITIES LTD ("BREWIN DOLPHIN") ON BEHALF OF SYNERGY HEALTHCARE PLC "SYNERGY HEALTHCARE") FOR ISOTRON PLC ("ISOTRON") OFFER DOCUMENT POSTED Further to its announcement of 26 October 2006, Synergy Healthcare announcesthat the offer document (the "Offer Document") containing the full terms andconditions of the Offer for Isotron has today been posted to Isotronshareholders, together with the related Form of Acceptance and an equivalentdocument containing further information relating to Synergy Healthcare (the"Equivalent Document"). Synergy Healthcare also announces that a circular, containing notice of anextraordinary general meeting of Synergy Healthcare shareholders to be held at10.30am on 27 November 2006 (the "Synergy Circular") has today been posted toSynergy Healthcare shareholders, together with the related Form of Proxy. Copies of the documents posted today by Synergy Healthcare may be inspected(during normal business hours only on any weekday) at the offices of TaylorWessing, Carmelite, 50 Victoria Embankment, Blackfriars, London EC4Y 0DXthroughout the period during which the Offer remains open for acceptance. Enquiries: Synergy Healthcare plc 01332 387 100Richard Steeves, Chief ExecutiveIvan Jacques, Group Finance Director Brewin Dolphin Securities Ltd 0845 270 8600(financial adviser to Synergy Healthcare)Mark BradyMatt DavisAndrew Emmott Buchanan 020 7466 5000(PR adviser to Synergy Healthcare)Tim AndersonMark Court This announcement does not constitute or form part of, an offer or invitation topurchase or subscribe for any securities. The Offer is be made solely by meansof the Offer Document and the Form of Acceptance accompanying the OfferDocument, which contain the full terms and conditions of the Offer includingdetails of how it may be accepted. Terms defined in the Offer Document have thesame meaning in this announcement. Brewin Dolphin is acting for Synergy Healthcare and for no-one else inconnection with the Offer and will not regard any other person as its client norbe responsible to anyone other than Synergy Healthcare for providing theprotections afforded to clients of Brewin Dolphin nor for providing advice inrelation to the Offer or any matter referred to in this announcement. BrewinDolphin is authorised and regulated by the Financial Services Authority. Under the provisions of Rule 8.3 of the City Code, if any person is, or becomes"interested" (directly or indirectly) in one per cent or more of any class of"relevant securities" of Isotron, all "dealings" in any relevant securities ofthe relevant company (including by means of an option in respect of, or aderivative referenced to, any such "relevant securities") must be publiclydisclosed by no later than 3.30p.m. on the Business Day following the date ofthe relevant transaction. This requirement will continue until the date on whichthe Offer becomes, or is declared, unconditional as to acceptances, lapses or isotherwise withdrawn or on which the "offer period" otherwise ends. If two ormore persons act together pursuant to an agreement or understanding, whetherformal or informal, to acquire an "interest" in "relevant securities" ofIsotron, they will be deemed to be a single person for the purpose of Rule 8.3of the City Code. Under the provisions of Rule 8.1 of the City Code, all "dealings" in "relevantsecurities" of Isotron by Synergy Healthcare or Isotron, or by any of theirrespective "associates", must be privately and publicly disclosed by no laterthan 12.00 noon on the Business Day following the date of the relevanttransaction. If you are in any doubt as to the application of Rule 8 to you, please contactan independent financial adviser authorised under the Financial Services andMarkets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk orcontact the Panel on telephone number +44 20 7382 9026, fax +44 20 7236 7005. A disclosure table, giving details of the companies in whose "relevantsecurities" "dealings" should be disclosed, and the number of such securities inissue, can also be found on the Panel's website. The availability of the Offer to Isotron Shareholders who are not resident inthe United Kingdom may be affected by the laws of the relevant jurisdictions inwhich they are located. Persons who are not resident in the United Kingdomshould inform themselves about, and observe, applicable legal or regulatoryrequirements of their jurisdiction. The Offer will not be made, directly or indirectly, in or into, or by use of themails, or by any means or instrumentality (including, without limitation, telex,facsimile transmission, telephone, internet or other forms of electroniccommunication) of interstate or foreign commerce of, or by any facilities of anational securities exchange of, the United States, Canada, Australia, SouthAfrica or Japan or any other jurisdiction if to do so would constitute aviolation of the relevant laws of such jurisdiction and the Offer cannot beaccepted by any such use, means or instrumentality or otherwise from or withinthe United States, Canada, Australia, South Africa or Japan or any otherjurisdiction if to do so would constitute a violation of the relevant laws ofsuch jurisdiction. Accordingly, copies of this announcement are not being, andmust not be, mailed or otherwise forwarded, distributed or sent in or into orfrom any such jurisdiction. The directors of Synergy Healthcare accept responsibility for the informationcontained in this announcement, other than that relating to Isotron which hasbeen compiled from published sources and in respect of which the onlyresponsibility accepted by the directors of Synergy Healthcare is forcorrectness and fairness of the reproduction and presentation of suchinformation. To the best of the knowledge and belief of the directors of SynergyHealthcare (who have taken all reasonable care to ensure that such is the case),the information contained in this document for which they take responsibility isin accordance with the fact and does not omit anything likely to affect theimpact of such information. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SYR.L